Kuros Biosciences Ltd. (CSBTF)
26.00
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Kuros Biosciences Market Cap : 9.378M for June 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 09, 2026 | 9.378M |
| June 08, 2026 | 9.378M |
| June 05, 2026 | 8.927M |
| June 04, 2026 | 8.927M |
| June 03, 2026 | 8.927M |
| June 02, 2026 | 8.927M |
| June 01, 2026 | 8.927M |
| May 29, 2026 | 8.927M |
| May 28, 2026 | 8.927M |
| May 27, 2026 | 969.69M |
| May 26, 2026 | 969.69M |
| May 22, 2026 | 969.69M |
| May 21, 2026 | 969.69M |
| May 20, 2026 | 969.69M |
| May 19, 2026 | 969.69M |
| May 18, 2026 | 969.69M |
| May 15, 2026 | 969.69M |
| May 14, 2026 | 969.69M |
| May 13, 2026 | 969.69M |
| May 12, 2026 | 969.69M |
| May 11, 2026 | 987.32M |
| May 08, 2026 | 987.32M |
| May 07, 2026 | 987.32M |
| May 06, 2026 | 987.32M |
| May 05, 2026 | 987.32M |
| Date | Value |
|---|---|
| May 04, 2026 | 1.097B |
| May 01, 2026 | 1.097B |
| April 30, 2026 | 1.097B |
| April 29, 2026 | 1.097B |
| April 28, 2026 | 1.097B |
| April 27, 2026 | 1.097B |
| April 24, 2026 | 1.097B |
| April 23, 2026 | 1.172B |
| April 22, 2026 | 1.175B |
| April 21, 2026 | 1.175B |
| April 20, 2026 | 1.089B |
| April 17, 2026 | 1.089B |
| April 16, 2026 | 1.089B |
| April 15, 2026 | 1.089B |
| April 14, 2026 | 1.089B |
| April 13, 2026 | 1.089B |
| April 10, 2026 | 1.089B |
| April 09, 2026 | 1.089B |
| April 08, 2026 | 1.089B |
| April 07, 2026 | 1.089B |
| April 06, 2026 | 1.089B |
| April 02, 2026 | 1.089B |
| April 01, 2026 | 1.089B |
| March 31, 2026 | 1.089B |
| March 30, 2026 | 1.091B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Molecular Partners AG | 139.54M |
| BeOne Medicines Ltd. | 26.94B |
| AC Immune SA | 214.68M |
| CRISPR Therapeutics AG | 4.766B |
| Idorsia Ltd. | 1.442B |
Market Cap Related Metrics
| PE Ratio | 422.08 |
| PS Ratio | 6.986 |
| Price | 26.00 |
| Earnings Yield | 0.24% |
| Operating PE Ratio | 115.65 |
| Normalized PE Ratio | 422.08 |